About 20%-25% of the time, ALS manifests as bulbar symptoms, most typically speech problems, such as slurring, hoarseness, or decreased vocal volume. As the disease worsens, muscle atrophy and ...

Efgartigimod significantly improves MG-ADL and QMG scores in generalized myasthenia gravis, with early responses linked to shorter disease duration and severe bulbar symptoms. Early responders often ...